Both in Pharmaceuticals
Impact BioMedical vs NanoViricides
Over the past year IBO returned −39.0% and NNVC returned −27.7%; their daily moves had a correlation of -0.06.
IBO −39.0% NNVC −27.7%Growth of $1, one year, split-adjusted
| Metric | IBO | NNVC |
|---|---|---|
| Price | $4.10 | $1.38 |
| Market cap | $35.0M | $35.2M |
| Today | +1.99% | −3.50% |
| 1 month | −12.4% | −1.4% |
| 6 months | −48.8% | −5.5% |
| Year to date | −35.7% | +22.1% |
| 1 year | −39.0% | −32.0% |
| Revenue growth (YoY) | −57.1% | — |
| Gross margin | −533.3% | — |
| Net margin | −23300.0% | — |
| P/E (TTM) | 44.4× | — |
| Price / sales | 1,000.8× | — |
| Net cash | $10.0K | $2.8M |
| Dividend yield | — | — |
| Volatility (60d) | 736.6% | 90.2% |
| Short % of float | 2.6% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).